AmerisourceBergen Executive Vice President of Retail Strategy and President of Good Neighbor Pharmacy David W. Neu to Retire
April 22 2016 - 7:15AM
Business Wire
Brian Nightengale, RPh, PhD, President of
Xcenda to assume role as President of Good Neighbor Pharmacy
AmerisourceBergen Corporation (NYSE: ABC) today announced that
David W. Neu, Executive Vice President of Retail Strategy and
President of Good Neighbor Pharmacy will retire in the summer of
2016. Neu has served AmerisourceBergen for more than 30 years in an
array of leadership roles including heading the AmerisourceBergen
Drug Corporation. During his tenure with the company, Neu has
passionately championed the value of independent community pharmacy
to the health and pharmaceutical industry. Neu’s leadership extends
beyond AmerisourceBergen to numerous industry organizations
including his appointment as Board of Directors Chairman for the
Healthcare Distribution Management Association in 2012 and his
election to the board of the National Association of Chain Drug
Stores in 2015.
“Our company will continue to be inspired by Dave, and his
legacy will be AmerisourceBergen’s unwavering focus on providing
innovative and impactful support to community pharmacists,” said
Steven H. Collis, AmerisourceBergen’s Chairman, President and Chief
Executive Officer. “Dave has been a true friend and mentor to many
including me. He has inspired so many of us with his tremendous
energy, dedication to our customers and an approachable manner that
has motivated associates at every level of our organization.”
Brian Nightengale, RPh, PhD, President of Xcenda will
immediately assume the role of President of Good Neighbor Pharmacy.
Nightengale has more than 20 years of experience with Xcenda, a
part of AmerisourceBergen, leading efforts to demonstrate the value
of pharmaceutical products while improving patient access to
medications. As an original Xcenda employee, Nightengale played a
key role in growing the company from a startup to a global leader
in commercialization support for innovative medical treatments.
Prior to joining Xcenda, Nightengale served as an Assistant
Professor at the College of Pharmacy, University of Oklahoma Health
Sciences Center where he is currently a member of the National
Board of Advisors.
“In today’s healthcare landscape, independent pharmacists are
seeking partners who can help grow their business and their ability
to meet the needs of patients in communities across the country,”
said Robert P. Mauch, PharmD, PhD, President of AmerisourceBergen
Drug Corporation. “Brian’s pharmacy background, deep understanding
of the payer environment and clinical and commercial expertise will
offer exciting new perspective for Good Neighbor Pharmacy and will
enable us to honor Dave’s legacy by building the capabilities and
solutions we need to support independent community
pharmacists.”
About AmerisourceBergen
AmerisourceBergen is one of the largest global pharmaceutical
sourcing and distribution services companies, helping both
healthcare providers and pharmaceutical and biotech manufacturers
improve patient access to products and enhance patient care. With
services ranging from drug distribution and niche premium logistics
to reimbursement and pharmaceutical consulting services,
AmerisourceBergen delivers innovative programs and solutions across
the pharmaceutical supply channel in human and animal health. With
over $135 billion in annual revenue, AmerisourceBergen is
headquartered in Valley Forge, PA, and employs approximately 18,000
people. AmerisourceBergen is ranked #16 on the Fortune 500 list.
For more information, go to www.amerisourcebergen.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160422005204/en/
AmerisourceBergenLauren Moyer610-727-3696 – Office215-460-6981 –
Mobilelmoyer@AmerisourceBergen.com
AmerisourceBergen (NYSE:ABC)
Historical Stock Chart
From Aug 2024 to Sep 2024
AmerisourceBergen (NYSE:ABC)
Historical Stock Chart
From Sep 2023 to Sep 2024